CUSIP No. 03823M100
|
|
Page 2
of 13
|
(1)
|
Names
of reporting persons
The
IBS Turnaround Fund (QP) (A Limited Partnership)
|
(2)
|
Check
the appropriate box if a member of a group (see instructions)
(a)
☐ (b) ☐
|
(3)
|
SEC use only
|
(4)
|
Source
of funds (see instructions)
OO
|
(5)
|
Check
box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
(6)
|
Citizenship
or place of organization
Massachusetts
|
Number
of shares beneficially owned by each reporting person with:
|
(7)
|
Sole
voting power
12,320,643
(1)
|
(8)
|
Shared
voting power
-0-
|
(9)
|
Sole
dispositive power
12,320,643
(1)
|
(10)
|
Shared
dispositive power
-0-
|
(11)
|
Aggregate
amount beneficially owned by each reporting person
12,320,643
(1)
|
(12)
|
Check box if the aggregate amount in Row (11) excludes certain shares (see instructions) ☐
|
(13)
|
Percent
of class represented by amount in Row (11)
6.017%
(1)(2)
|
(14)
|
Type
of reporting person (see instructions)
PN
|
|
|
|
|
|
(1)
|
Includes
the 665,060 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Turnaround Fund QP (A Limited Partnership).
|
|
(2)
|
Based
on 204,736,762 shares of the Issuer’s common stock outstanding as of November 22,
2021, as disclosed in the Issuer’s 10-Q for the quarterly period ended September
30, 2021, filed with the Securities and Exchange Commission (the “SEC”)
on November 22, 2021.
|
CUSIP No. 03823M100
|
|
Page 3
of 13
|
(1)
|
Names
of reporting persons
The
IBS Turnaround Fund (A Limited Partnership)
|
(2)
|
Check
the appropriate box if a member of a group (see instructions)
(a)
☐ (b) ☐
|
(3)
|
SEC use only
|
(4)
|
Source
of funds (see instructions)
OO
|
(5)
|
Check
box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
(6)
|
Citizenship
or place of organization
Massachusetts
|
Number
of shares beneficially owned by each reporting person with:
|
(7)
|
Sole
voting power
6,232,314
(1)
|
(8)
|
Shared
voting power
-0-
|
(9)
|
Sole
dispositive power
6,232,314
(1)
|
(10)
|
Shared
dispositive power
-0-
|
(11)
|
Aggregate
amount beneficially owned by each reporting person
6,232,314
(1)
|
(12)
|
Check box if the aggregate amount in Row (11) excludes certain shares (see instructions) ☐
|
(13)
|
Percent
of class represented by amount in Row (11)
3.044%
(1)(2)
|
(14)
|
Type
of reporting person (see instructions)
PN
|
|
|
|
|
|
(1)
|
Includes
the 329,317 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Turnaround Fund (A Limited Partnership).
|
|
(2)
|
Based
on 204,736,762 shares of the Issuer’s common stock outstanding as of November 22,
2021, as disclosed in the Issuer’s 10-Q for the quarterly period ended September
30, 2021, filed with the SEC on November 22, 2021.
|
CUSIP No. 03823M100
|
|
Page 4
of 13
|
(1)
|
Names
of reporting persons
The
IBS Opportunity Fund, Ltd.
|
(2)
|
Check
the appropriate box if a member of a group (see instructions)
(a)
☐ (b) ☐
|
(3)
|
SEC use only
|
(4)
|
Source
of funds (see instructions)
OO
|
(5)
|
Check
box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
(6)
|
Citizenship
or place of organization
Commonwealth
of the Bahamas
|
Number
of shares beneficially owned by each reporting person with:
|
(7)
|
Sole
voting power
1,539,555
(1)
|
(8)
|
Shared
voting power
-0-
|
(9)
|
Sole
dispositive power
1,539,555
(1)
|
(10)
|
Shared
dispositive power
-0-
|
(11)
|
Aggregate
amount beneficially owned by each reporting person
1,539,555
(1)
|
(12)
|
Check
box if the aggregate amount in Row (11) excludes certain shares
(see
instructions) ☐
|
(13)
|
Percent
of class represented by amount in Row (11)
0.752%
(1)(2)
|
(14)
|
Type
of reporting person (see instructions)
CO
|
|
|
|
|
|
(1)
|
Includes
the 64,401 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Opportunity Fund, Ltd.
|
|
(2)
|
Based
on 204,736,762 shares of the Issuer’s common stock outstanding as of November 22,
2021, as disclosed in the Issuer’s 10-Q for the quarterly period ended September
30, 2021, filed with the SEC on November 22, 2021.
|
CUSIP No. 03823M100
|
|
Page 5
of 13
|
(1)
|
Names
of reporting persons
IBS
Capital LLC
|
(2)
|
Check
the appropriate box if a member of a group (see instructions)
(a)
☐ (b) ☐
|
(3)
|
SEC use only
|
(4)
|
Source
of funds (see instructions)
OO
|
(5)
|
Check
box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
(6)
|
Citizenship
or place of organization
Massachusetts
|
Number
of shares beneficially owned by each reporting person with:
|
(7)
|
Sole
voting power
20,092,512
(1)
|
(8)
|
Shared
voting power
-0-
|
(9)
|
Sole
dispositive power
20,092,512
(1)
|
(10)
|
Shared
dispositive power
-0-
|
(11)
|
Aggregate
amount beneficially owned by each reporting person
20,092,512
(1)
|
(12)
|
Check box if the aggregate amount in Row (11) excludes certain shares (see instructions) ☐
|
(13)
|
Percent
of class represented by amount in Row (11)
9.814%
(1) (2)
|
(14)
|
Type
of reporting person (see instructions)
CO
|
|
|
|
|
|
(1)
|
Includes
the 64,401 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Opportunity Fund, Ltd., 329,317 shares of Common Stock issuable upon
conversion of the Options and Warrants held by The IBS Turnaround Fund (A Limited Partnership)
and 665,060 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Turnaround Fund QP (A Limited Partnership).
|
|
(2)
|
Based
on 204,736,762 shares of the Issuer’s common stock outstanding as of November 22,
2021, as disclosed in the Issuer’s 10-Q for the quarterly period ended September
30, 2021, filed with the SEC on November 22, 2021.
|
CUSIP No. 03823M100
|
|
Page 6
of 13
|
(1)
|
Names
of reporting persons
David
A. Taft
|
(2)
|
Check
the appropriate box if a member of a group (see instructions)
(a)
☐ (b) ☐
|
(3)
|
SEC use only
|
(4)
|
Source
of funds (see instructions)
OO
|
(5)
|
Check
box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
(6)
|
Citizenship
or place of organization
United
States of America
|
Number
of shares beneficially owned by each reporting person with:
|
(7)
|
Sole
voting power
20,092,512
(1)
|
(8)
|
Shared
voting power
-0-
|
(9)
|
Sole
dispositive power
20,092,512
(1)
|
(10)
|
Shared
dispositive power
-0-
|
(11)
|
Aggregate
amount beneficially owned by each reporting person
20,092,512
(1)
|
(12)
|
Check box if the aggregate amount in Row (11) excludes certain shares (see instructions) ☐
|
(13)
|
Percent
of class represented by amount in Row (11)
9.814%
(1)(2)
|
(14)
|
Type
of reporting person (see instructions)
IN
|
|
|
|
|
|
(1)
|
Includes
the 64,401 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Opportunity Fund, Ltd., 329,317 shares of Common Stock issuable upon
conversion of the Options and Warrants held by The IBS Turnaround Fund (A Limited Partnership)
and 665,060 shares of Common Stock issuable upon conversion of the Options and Warrants
held by The IBS Turnaround Fund QP (A Limited Partnership).
|
|
(2)
|
Based
on 204,736,762 shares of the Issuer’s common stock outstanding as of November 22,
2021, as disclosed in the Issuer’s 10-Q for the quarterly period ended September
30, 2021, filed with the SEC on November 22, 2021.
|
Amendment
No. 17 to Schedule 13D
This
Amendment No. 17 to Schedule 13D (“Schedule 13D” or this “Statement”) amends and supplements
the initial statement on Schedule 13D relating to the Common Stock of Applied Minerals, Inc. (f/k/a Atlas Mining Company) (the
“Issuer”) filed with the Securities and Exchange Commission (“Commission”) on July 11, 2005
by The IBS Turnaround Fund (QP) (A Limited Partnership) (“QP Turnaround Fund”) and IBS Capital Corporation,
as amended by Amendment No. 1 filed on July 12, 2005, as amended by Amendment No. 2 filed on October 16, 2006, as amended by Amendment
No. 3 filed on January 23, 2007, as amended by Amendment No. 4 filed on October 12, 2007, as amended by Amendment No. 5 filed
on December 13, 2007, as amended by Amendment No. 6 filed on June 4, 2008, as amended by Amendment No. 7 filed on July 2, 2008,
as amended by Amendment No. 8 filed on October 7, 2008, as amended by Amendment No. 9 filed on October 27, 2008, as amended by
Amendment No. 10 filed on January 12, 2009, as amended by Amendment No. 11 filed on May 20, 2009, as amended by Amendment No.
12 filed on January 29, 2010, as amended by Amendment No. 13 filed on April 14, 2011, as amended by Amendment No. 14 filed on
July 5, 2011, as amended by Amendment No. 15 filed on November 10, 2012, and as amended by Amendment No. 16 filed on November
12, 2014.
As
previously reported, IBS Capital LLC, a Massachusetts limited liability company (“IBS Capital”), is the general
partner of the QP Turnaround Fund and The IBS Turnaround Fund (A Limited Partnership), a Massachusetts limited partnership (“LP
Turnaround Fund”), and the investment manager of The IBS Opportunity Fund, Ltd., an international business company organized
under the laws of the Commonwealth of the Bahamas (the “Opportunity Fund”).
|
Item
1.
|
Security
and Issuer.
|
IBS
Capital is the general partner of the QP Turnaround Fund and LP Turnaround Fund, and the investment manager of the Opportunity
Fund. David A. Taft (“Mr. Taft”) is a member and the president of IBS Capital. This Schedule 13D is filed jointly
by QP Turnaround Fund, the LP Turnaround Fund, the Opportunity Fund, IBS Capital, and Mr. Taft (collectively referred to herein
as the “Filers,” each a “Filer”).
The
class of equity securities to which this Schedule 13D relates is the Common Stock, $0.001 par value (“Common Stock”
or “Shares”) of the Issuer. The address of the Issuer’s principal executive office is 1200 Silver City
Road, PO Box 432, Eureka, UT 84628.
|
Item
2.
|
Identity
and Background.
|
The
QP Turnaround Fund is a Massachusetts limited partnership. Its principal business is investing in securities. The address of its
principal office is One International Place, Suite 3120, Boston, Massachusetts 02110. During the past five years, it has not been
convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). During the past five years, it has
not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such
proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with respect to such laws.
The
LP Turnaround Fund is a Massachusetts limited partnership. Its principal business is investing in securities. The address of its
principal office is One International Place, Suite 3120, Boston, Massachusetts 02110. During the past five years, it has not been
convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). During the past five years, it has
not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such
proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with respect to such laws.
The
Opportunity Fund is an international business company organized under the laws of the Commonwealth of the Bahamas. Its principal
business is investing in securities. The address of its principal office is c/o Lennox Paton Corporate Services Limited is 3 Bayside
Executive Park, West Bay Street & Blake Road, P.O. Box N-4875, Nassau, Bahamas. The address of the Opportunity Fund’s
investment manager is One International Place, Suite 3120, Boston, Massachusetts 02110. The names, principal occupations, addresses
and citizenship of its directors are set forth in Schedule A hereto. During the past five years, it has not been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors). During the past five years, it has not been a party
to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was
or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation with respect to such laws.
IBS
Capital is a Massachusetts limited liability company. Its principal business is investing in securities. The address of its principal
office is One International Place, Suite 3120, Boston, Massachusetts 02110. During the past five years, it has not been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors). During the past five years, it has not been a
party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding,
was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with respect to such laws.
CUSIP No. 03823M100
|
|
Page 8
of 13
|
Mr.
Taft is a member and the president of IBS Capital. His business address is One International Place, Suite 3120, Boston, Massachusetts
02110. His principal occupation is investing in securities. During the past five years, he has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors). During the past five years, he has not been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject
to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal
or state securities laws or finding any violation with respect to such laws. He is a citizen of the United States of America.
|
Item
3.
|
Source
and Amount of Funds or Other Consideration.
|
Item
3 of Schedule 13D is supplemented as follows:
Pursuant
to the Purchase Agreement (as defined below) the Purchaser (as defined below) acquired the securities for a cash payment in immediately
available funds.
|
Item
4.
|
Purpose
of Transaction.
|
Item
4 of Schedule 13D is supplemented and superseded, as the case may be, as follows:
Sale
of Common Stock. The LP Turnaround Fund and the QP Turnaround Fund sold Shares of the Issuer to a third-party purchaser (the
“Purchaser”) in a private transaction pursuant to a Secondary Securities Purchase Agreement dated as of December
13, 2021 (the “Purchase Agreement”). The LP Turnaround Fund sold 1,403,000 Shares to the Purchaser and the
QP Turnaround Fund sold 3,597,000 Shares to the Purchaser.
Sale
of 10% PIK-Election Convertible Notes. The LP Turnaround Fund, the QP Turnaround Fund and the Opportunity Fund sold certain
derivative securities to the Purchaser pursuant to the Purchase Agreement. On December 31, 2020, each of the LP Turnaround Fund,
the QP Turnaround Fund and the Opportunity Fund were issued a 10% PIK-Election Convertible Note (each a “Note”
and collectively, the “Notes”). The LP Fund sold $1,427,792 of principal under the Note to the Purchaser for
$57,111.68, which principal amount is convertible into 4,199,388 Shares. The QP Fund sold $2,867,160 of principal under the Note
to the Purchaser for $114,686.40, which principal amount is convertible into 8,432,824 Shares. The Opportunity Fund sold $278,582
of principal under the Note to the Purchaser for $11,143.28, which principal amount is convertible into 819,359 Shares.
The
Notes and the Shares were transferred to the Purchaser on December 17, 2021, and the transactions described in this Item 4 were
effected at the same time.
Investment
Purposes. The Filers have sold the Shares in the ordinary course of business. The Filers intend to review their investment
in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer’s financial
position and strategic direction, price levels of the Common Stock, conditions in the securities market and general economic and
industry conditions, the Filers may in the future take such actions with respect to their investment in the Issuer as they deem
appropriate, including, but not limited to, purchasing additional Common Stock or other securities of the Issuer or selling some
or all of their securities on the open market, in private transactions or otherwise, communicating with the Issuer or other investors
or stockholders or conducting a proxy solicitation with respect to the election of directors of the Issuer. Except as set forth
herein, the Filers do not have any present plan or proposal that would relate to or result in any of the matters set forth in
subparagraphs (a)-(j) of Item 4 of Schedule 13D.
CUSIP No. 03823M100
|
|
Page 9
of 13
|
|
Item
5.
|
Interest
in Securities of the Issuer.
|
(a) The
percentages used in this Statement are calculated on the basis of 204,736,762 Shares outstanding, as reported in the Issuer’s
10-Q for the quarterly period ended September 30, 2021, filed with the Commission on November 22, 2021.
|
•
|
As
of December 21, 2021, the QP Turnaround Fund directly beneficially owned, in the aggregate,
12,320,643 Shares, which represents 6.017% of the Issuer’s Common Stock. The aggregate
Shares include 665,060 Shares issuable upon conversion of certain Options and Warrants
held by the QP Turnaround Fund.
|
|
•
|
As
of December 21, 2021, the LP Turnaround Fund directly beneficially owned, in the aggregate,
6,232,314 Shares, which represents 3.044% of the Issuer’s Common Stock. The aggregate
Shares include 329,317 Shares issuable upon conversion of certain Options and Warrants
held by the LP Turnaround Fund.
|
|
•
|
As
of December 21, 2021, the Opportunity Fund beneficially owned, in the aggregate, 1,539,555
Shares, which represents 0.752% of the Issuer’s Common Stock. The aggregate Shares
include 64,401 Shares issuable upon conversion of certain Options and Warrants held by
the Opportunity Fund.
|
|
•
|
As
of December 21, 2021, IBS Capital owned, in the aggregate, 20,092,512 Shares, which represented
9.814% of the Issuer’s Common Stock, which consisted of 12,320,643 Shares directly
beneficially owned by the QP Turnaround Fund, 6,232,314 Shares directly beneficially
owned by the LP Turnaround Fund, and 1,539,555 Shares directly beneficially owned by
the Opportunity Fund.
|
|
•
|
As
of December 21, 2021, Mr. Taft indirectly beneficially owned the 20,092,512 Shares that
were indirectly beneficially owned by IBS Capital, which represented 9.814% of the Issuer’s
Common Stock.
|
(b)
The information contained in table form in Rows 7 through 11 on each of pages 2, 3, 4, 5 and 6 hereof, which
relates to beneficial ownership, voting and disposition of Shares, is hereby incorporated by reference.
(c) Not
applicable.
(d)
The disclosure regarding the relationship among the Filers set forth in Item 1 of this Schedule 13D is
incorporated by reference herein.
(e)
Not applicable.
|
Item
6.
|
Contracts,
Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item
6 of Schedule 13D is supplemented as follows:
Purchase
Agreement. As described in Item 4, the Purchaser, the QP Turnaround Fund the LP Turnaround Fund and the Opportunity Fund entered
into the Purchase Agreement.
Directorship
of Mr. Taft. As of the date hereof, Mr. Taft is no longer a director of the Issuer and Mr. Taft’s directorship ended
in December 2017.
Other
Matters. Other than as described above, to each Filer’s knowledge, there are no contracts, arrangements, understandings
or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to
any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder’s fees, joint
ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding
of proxies.
CUSIP No. 03823M100
|
|
Page 10
of 13
|
|
Item
7.
|
Material
to Be Filed as Exhibits.
|
The
following document is filed herewith:
|
Exhibit
|
|
Description
|
|
1
|
|
Joint Filing Agreement, dated as of December
21, 2021, by and among The IBS Turnaround Fund (QP) (A Limited Partnership), The IBS Turnaround Fund (A Limited Partnership),
The IBS Opportunity Fund, Ltd., IBS Capital LLC, and David A. Taft.
|
|
|
|
|
|
2
|
|
Secondary Securities Purchase Agreement, dated
December 13, 2021, by and among Geoffrey G. Scott The IBS Turnaround Fund (QP) (A Limited Partnership), The IBS Turnaround
Fund (A Limited Partnership) and The IBS Opportunity Fund, Ltd..
|
CUSIP No. 03823M100
|
|
Page 11
of 13
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
Date: December 21, 2021
|
|
|
|
|
|
|
|
THE IBS TURNAROUND FUND (QP) (A
LIMITED PARTNERSHIP)
|
|
|
By: IBS CAPITAL
LLC, its General Partner
|
|
|
|
|
|
|
|
|
By:
|
/s/ David
A. Taft
|
|
|
|
Name:
|
David A. Taft
|
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
THE IBS TURNAROUND FUND (A LIMITED
PARTNERSHIP)
|
|
|
By: IBS CAPITAL
LLC, its General Partner
|
|
|
|
|
|
|
|
|
By:
|
/s/ David
A. Taft
|
|
|
|
Name:
|
David A. Taft
|
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
THE IBS OPPORTUNITY FUND, LTD.
|
|
|
By: IBS CAPITAL
LLC, its Investment Manager
|
|
|
|
|
|
|
|
|
By:
|
/s/ David
A. Taft
|
|
|
|
Name:
|
David A. Taft
|
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
IBS CAPITAL LLC
|
|
|
|
|
|
|
|
|
By:
|
/s/ David
A. Taft
|
|
|
|
Name:
|
David A. Taft
|
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
DAVID A. TAFT
|
|
|
|
|
|
|
|
|
Signature:
|
/s/ David
A. Taft
|
|
|
|
Name:
|
David A. Taft
|
|
CUSIP No. 03823M100
|
|
Page 12
of 13
|
SCHEDULE
A
Name
|
Principal
Occupation
|
Principal
Business Address
|
Citizenship
|
David
A. Taft
|
Member
and President of IBS Capital LLC
|
One
International Place, Suite 3120, Boston, Massachusetts 02110
|
United
States of America
|
James
Home
|
Chief
Financial Officer of IBS Capital LLC
|
One
International Place, Suite 3120, Boston, Massachusetts 02110
|
United
States of America
|
Shonalee
Monroe
|
Vice
President of Operations of Genesis Fund Services Limited
|
P.O.
Box N-9058, Nassau, Bahamas
|
Bahamas
|
CUSIP No. 03823M100
|
|
Page 13
of 13
|
Exhibit
1
JOINT
FILING AGREEMENT
The
undersigned agree that the statement on Schedule 13D/A with respect to the common stock Applied Minerals, Inc., dated as of December
21, 2021, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to
and in accordance with the provisions of Rule 13d under the Securities Exchange Act of 1934, as amended.
|
|
IBS
CAPITAL LLC
Date:
December 21, 2021
|
|
|
|
|
|
By:
|
/s/
David A. Taft
|
|
|
Name:
|
David
A. Taft
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
THE
IBS TURNAROUND FUND (A LIMITED PARTNERSHIP)
Date:
December 21, 2021
|
|
|
|
|
By:
By:
|
IBS
Capital LLC
General
Partner
/s/
David A. Taft
|
|
|
Name:
|
David
A. Taft
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
THE
IBS TURNAROUND FUND (QP) (A LIMITED PARTNERSHIP)
Date:
December 21, 2021
|
|
|
|
|
By:
By:
|
IBS
Capital LLC
General
Partner
/s/
David A. Taft
|
|
|
Name:
|
David
A. Taft
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
THE
IBS OPPORTUNITY FUND, LTD.
Date:
December 21, 2021
|
|
|
|
|
|
By:
By:
|
IBS
Capital LLC
Investment
Manager
/s/
David A. Taft
|
|
|
Name:
|
David
A. Taft
|
|
|
Title:
|
President
|
|
|
|
|
|
|
Date:
December 21, 2021
|
|
|
|
|
Signature:
|
/s/
David A. Taft
|
|
|
Name:
|
David
A. Taft
|
|
|
|
|
|
|
|